With Merck’s COVID Antiviral Announcement, Can the Pharma Pipeline Build Treatment Momentum?

 

At the start of the month, pharmaceutical company Merck dropped big news: It has developed a COVID antiviral drug that would cut hospitalization and mortality risks by 50%. In the drug’s study, patients taking the placebo pill saw 14% hospitalization rate and eight deaths, while the trial group with Merck’s drug had only 7% hospitalized and zero deaths.

This appears to be just the tip of the iceberg; Kaiser Health News reports at least three COVID antiviral candidates, including Merck’s, going through late-stage clinical trials, meaning a variety of COVID drugs could be on patient’s prescriptions here soon. What’ll be some of the positive domino effects to come from approval of COVID antivirals, not only on the pharmaceutical production pipeline, but on the general population’s health? Ira Leiderman, managing director of the healthcare practice at Cassel Salpeter & Co., gave MarketScale his take on the coming treatments.

Follow us on social media for the latest updates in B2B!

Image

Latest

training
Empowering Teams Through a Modern Training Culture
November 13, 2025

Training may be the backbone of any skilled trade, but in waterproofing—where mistakes can compromise entire structures—it becomes a defining competitive advantage. At Southwest Construction Services, the evolution of training reflects a larger industry shift: seasoned crews now rely less on formal classroom sessions and more on hyper-focused, on-site guidance tailored to the…

Read More
quality assurance
Ensuring Excellence: How Quality Assurance Shapes Every Successful Project
November 13, 2025

In an era of rising climate volatility and tighter construction tolerances, waterproofing has quietly become one of the most consequential guardians of a building’s long-term health. Too often, the industry treats it as an afterthought—something buried behind walls, beneath slabs, or under layers of finish—but the truth is that its success or failure can…

Read More
safety
Safety, Pride & Zero Defects: The New Standard in Construction Excellence
November 13, 2025

In an era when construction headlines often center on delays, overruns, and litigation, the companies that quietly build with integrity are shaping the industry’s future in far more meaningful ways. The most enduring structures aren’t defined merely by their materials but by the standards and culture behind them—standards that treat quality not as…

Read More
Startup
Turning Corporate Discipline into Startup Momentum: The New Blueprint for Modern Marketing Leadership
November 12, 2025

As the business landscape grows faster and more unpredictable, marketing leaders who can balance the discipline of big-company strategy with the scrappiness of startups are redefining what modern leadership looks like. Brian Fravel’s journey from global tech giant Intel to high-growth SaaS and cybersecurity companies highlights how adaptability, curiosity, and hands-on execution drive success across…

Read More